Related Experiment Video
Updated: May 29, 2026
08:36
The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
New insight on hepatic encephalopathy: a comprehensive review
Ahmed A Sedik1, Renad Alrefaei2
1Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.
Summary
Hepatic encephalopathy (HE) involves brain dysfunction from liver disease, affecting cognition and behavior. Understanding its complex causes beyond high ammonia is key to improving patient outcomes.
Area of Science:
- Hepatology and Neurology
- Gastroenterology
- Neuroscience
Background:
- Hepatic encephalopathy (HE) is a serious complication of liver dysfunction, impacting patient morbidity and mortality.
- Manifestations range from mild cognitive issues to severe neurological deficits.
- Hyperammonemia is a key factor, but not the sole cause of HE.
Purpose of the Study:
- To provide a comprehensive review of hepatic encephalopathy.
- To discuss pathogenesis, clinical spectrum, diagnosis, and treatment.
- To highlight recent advances for improved patient outcomes.
Main Methods:
- Literature review of pathogenesis, clinical presentation, diagnosis, and therapies for HE.
- Focus on multifactorial mechanisms including neuroinflammation and gut-liver-brain axis.
- Analysis of current and emerging therapeutic strategies.
Main Results:
- HE presents a wide range of neuropsychiatric symptoms.
- Pathogenesis involves hyperammonemia, neuroinflammation, oxidative stress, and gut-liver-brain axis dysregulation.
- Ammonia levels do not always correlate with clinical severity.
Conclusions:
- HE is a complex condition with multifactorial causes.
- Further research into diverse mechanisms is needed.
- Advances in understanding and treatment are crucial for managing HE.
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...